Multicenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma MRI criteria for poor-risk rectal cancer were tumors within 1 ...

Guidelines recommend chemoradiation (CRT) before surgery for patients with clinical stage II-III rectal cancer in order to lower the risk of locoregional recurrence, but there is a growing concern ...

Total mesorectal excision (TME) involving resection of the fatty tissue around the rectum is a successful treatment for colorectal cancer. Interim results of a large, prospective, randomized, ...

TME is widely accepted as a treatment for stage III and IV rectal cancer, but it comes at the cost of urogenital and anorectal dysfunction, permanent fistulas, and poor quality of life. Local excision ...

Please provide your email address to receive an email when new articles are posted on . MRI can help determine which individuals with rectal cancer may not need surgery following neoadjuvant therapy.

TNT achieved a 93.7% complete response rate and 87.5% organ preservation in stage I rectal cancer patients. TNT may offer an organ-preserving alternative to surgery, especially for low-lying tumors, ...